VEGF-B is a potent antioxidant

Pachiappan Arjunan, Xianchai Lin, Zhongshu Tang, Yuxiang Du, Anil Kumar, Lixian Liu, Xiangke Yin, Lijuan Huang, Wei Chen, Qishan Chen, Zhimin Ye, Shasha Wang, Haiqing Kuang, Linbin Zhou, Kai Xu, Xue Chen, Haitao Zeng, Weisi Lu, Yihai Cao, Yizhi LiuChen Zhao, Xuri Li

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

VEGF-B was discovered a long time ago. However, unlike VEGF-A, whose function has been extensively studied, the function of VEGF-B and the mechanisms involved still remain poorly understood. Notwithstanding, drugs that inhibit VEGF-B and other VEGF family members have been used to treat patients with neovascular diseases. It is therefore critical to have a better understanding of VEGF-B function and the underlying mechanisms. Here, using comprehensive methods and models, we have identified VEGF-B as a potent antioxidant. Loss of Vegf-b by gene deletion leads to retinal degeneration in mice, and treatment with VEGF-B rescues retinal cells from death in a retinitis pigmentosa model. Mechanistically, we demonstrate that VEGF-B upregulates numerous key antioxidative genes, particularly, Gpx1. Loss of Gpx1 activity largely diminished the antioxidative effect of VEGF-B, demonstrating that Gpx1 is at least one of the critical downstream effectors of VEGF-B. In addition, we found that the antioxidant function of VEGF-B is mediated mainly by VEGFR1. Given that oxidative stress is a crucial factor in numerous human diseases, VEGF-B may have therapeutic value for the treatment of such diseases.

Original languageEnglish (US)
Pages (from-to)10351-10356
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume115
Issue number41
DOIs
StatePublished - Oct 9 2018

Fingerprint

Vascular Endothelial Growth Factor B
Antioxidants
Vascular Endothelial Growth Factor A
Retinal Degeneration
Retinitis Pigmentosa
Gene Deletion

Keywords

  • Antioxidant
  • Gpx1
  • Oxidative stress
  • Retinal degeneration
  • VEGF-B

ASJC Scopus subject areas

  • General

Cite this

VEGF-B is a potent antioxidant. / Arjunan, Pachiappan; Lin, Xianchai; Tang, Zhongshu; Du, Yuxiang; Kumar, Anil; Liu, Lixian; Yin, Xiangke; Huang, Lijuan; Chen, Wei; Chen, Qishan; Ye, Zhimin; Wang, Shasha; Kuang, Haiqing; Zhou, Linbin; Xu, Kai; Chen, Xue; Zeng, Haitao; Lu, Weisi; Cao, Yihai; Liu, Yizhi; Zhao, Chen; Li, Xuri.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, No. 41, 09.10.2018, p. 10351-10356.

Research output: Contribution to journalArticle

Arjunan, P, Lin, X, Tang, Z, Du, Y, Kumar, A, Liu, L, Yin, X, Huang, L, Chen, W, Chen, Q, Ye, Z, Wang, S, Kuang, H, Zhou, L, Xu, K, Chen, X, Zeng, H, Lu, W, Cao, Y, Liu, Y, Zhao, C & Li, X 2018, 'VEGF-B is a potent antioxidant', Proceedings of the National Academy of Sciences of the United States of America, vol. 115, no. 41, pp. 10351-10356. https://doi.org/10.1073/pnas.1801379115
Arjunan, Pachiappan ; Lin, Xianchai ; Tang, Zhongshu ; Du, Yuxiang ; Kumar, Anil ; Liu, Lixian ; Yin, Xiangke ; Huang, Lijuan ; Chen, Wei ; Chen, Qishan ; Ye, Zhimin ; Wang, Shasha ; Kuang, Haiqing ; Zhou, Linbin ; Xu, Kai ; Chen, Xue ; Zeng, Haitao ; Lu, Weisi ; Cao, Yihai ; Liu, Yizhi ; Zhao, Chen ; Li, Xuri. / VEGF-B is a potent antioxidant. In: Proceedings of the National Academy of Sciences of the United States of America. 2018 ; Vol. 115, No. 41. pp. 10351-10356.
@article{162179fea9b548b4b07a47df741b8a47,
title = "VEGF-B is a potent antioxidant",
abstract = "VEGF-B was discovered a long time ago. However, unlike VEGF-A, whose function has been extensively studied, the function of VEGF-B and the mechanisms involved still remain poorly understood. Notwithstanding, drugs that inhibit VEGF-B and other VEGF family members have been used to treat patients with neovascular diseases. It is therefore critical to have a better understanding of VEGF-B function and the underlying mechanisms. Here, using comprehensive methods and models, we have identified VEGF-B as a potent antioxidant. Loss of Vegf-b by gene deletion leads to retinal degeneration in mice, and treatment with VEGF-B rescues retinal cells from death in a retinitis pigmentosa model. Mechanistically, we demonstrate that VEGF-B upregulates numerous key antioxidative genes, particularly, Gpx1. Loss of Gpx1 activity largely diminished the antioxidative effect of VEGF-B, demonstrating that Gpx1 is at least one of the critical downstream effectors of VEGF-B. In addition, we found that the antioxidant function of VEGF-B is mediated mainly by VEGFR1. Given that oxidative stress is a crucial factor in numerous human diseases, VEGF-B may have therapeutic value for the treatment of such diseases.",
keywords = "Antioxidant, Gpx1, Oxidative stress, Retinal degeneration, VEGF-B",
author = "Pachiappan Arjunan and Xianchai Lin and Zhongshu Tang and Yuxiang Du and Anil Kumar and Lixian Liu and Xiangke Yin and Lijuan Huang and Wei Chen and Qishan Chen and Zhimin Ye and Shasha Wang and Haiqing Kuang and Linbin Zhou and Kai Xu and Xue Chen and Haitao Zeng and Weisi Lu and Yihai Cao and Yizhi Liu and Chen Zhao and Xuri Li",
year = "2018",
month = "10",
day = "9",
doi = "10.1073/pnas.1801379115",
language = "English (US)",
volume = "115",
pages = "10351--10356",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "41",

}

TY - JOUR

T1 - VEGF-B is a potent antioxidant

AU - Arjunan, Pachiappan

AU - Lin, Xianchai

AU - Tang, Zhongshu

AU - Du, Yuxiang

AU - Kumar, Anil

AU - Liu, Lixian

AU - Yin, Xiangke

AU - Huang, Lijuan

AU - Chen, Wei

AU - Chen, Qishan

AU - Ye, Zhimin

AU - Wang, Shasha

AU - Kuang, Haiqing

AU - Zhou, Linbin

AU - Xu, Kai

AU - Chen, Xue

AU - Zeng, Haitao

AU - Lu, Weisi

AU - Cao, Yihai

AU - Liu, Yizhi

AU - Zhao, Chen

AU - Li, Xuri

PY - 2018/10/9

Y1 - 2018/10/9

N2 - VEGF-B was discovered a long time ago. However, unlike VEGF-A, whose function has been extensively studied, the function of VEGF-B and the mechanisms involved still remain poorly understood. Notwithstanding, drugs that inhibit VEGF-B and other VEGF family members have been used to treat patients with neovascular diseases. It is therefore critical to have a better understanding of VEGF-B function and the underlying mechanisms. Here, using comprehensive methods and models, we have identified VEGF-B as a potent antioxidant. Loss of Vegf-b by gene deletion leads to retinal degeneration in mice, and treatment with VEGF-B rescues retinal cells from death in a retinitis pigmentosa model. Mechanistically, we demonstrate that VEGF-B upregulates numerous key antioxidative genes, particularly, Gpx1. Loss of Gpx1 activity largely diminished the antioxidative effect of VEGF-B, demonstrating that Gpx1 is at least one of the critical downstream effectors of VEGF-B. In addition, we found that the antioxidant function of VEGF-B is mediated mainly by VEGFR1. Given that oxidative stress is a crucial factor in numerous human diseases, VEGF-B may have therapeutic value for the treatment of such diseases.

AB - VEGF-B was discovered a long time ago. However, unlike VEGF-A, whose function has been extensively studied, the function of VEGF-B and the mechanisms involved still remain poorly understood. Notwithstanding, drugs that inhibit VEGF-B and other VEGF family members have been used to treat patients with neovascular diseases. It is therefore critical to have a better understanding of VEGF-B function and the underlying mechanisms. Here, using comprehensive methods and models, we have identified VEGF-B as a potent antioxidant. Loss of Vegf-b by gene deletion leads to retinal degeneration in mice, and treatment with VEGF-B rescues retinal cells from death in a retinitis pigmentosa model. Mechanistically, we demonstrate that VEGF-B upregulates numerous key antioxidative genes, particularly, Gpx1. Loss of Gpx1 activity largely diminished the antioxidative effect of VEGF-B, demonstrating that Gpx1 is at least one of the critical downstream effectors of VEGF-B. In addition, we found that the antioxidant function of VEGF-B is mediated mainly by VEGFR1. Given that oxidative stress is a crucial factor in numerous human diseases, VEGF-B may have therapeutic value for the treatment of such diseases.

KW - Antioxidant

KW - Gpx1

KW - Oxidative stress

KW - Retinal degeneration

KW - VEGF-B

UR - http://www.scopus.com/inward/record.url?scp=85054715400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054715400&partnerID=8YFLogxK

U2 - 10.1073/pnas.1801379115

DO - 10.1073/pnas.1801379115

M3 - Article

C2 - 30249667

AN - SCOPUS:85054715400

VL - 115

SP - 10351

EP - 10356

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 41

ER -